GRACE DADA NP
Prescription History 1972995199
Nurse Practitioner - Family in Rowlett, TX


Quality Rating: 90.01 out of 100 score

NPI Status: Active since February 25, 2015

Contact Information

3430 LAKEVIEW PKWY
ROWLETT, TX
ZIP 75088
Phone: (972) 475-2597

Get Directions

Prescription History for Informed Healthcare Decisions

When choosing a healthcare provider, especially one who prescribes medications, having access to their prescribing history can be invaluable. This page offers detailed insights into the prescriptions GRACE DADA NP has written for Medicare beneficiaries in the past, empowering both current and prospective patients to make informed decisions about their healthcare.

Why This Information Matters

This Medicare Part D dataset provides transparency into the provider’s prescribing patterns, helping you understand the scope and nature of their pharmaceutical care. Here’s what you can learn:

  • Prescribing Trends: See which medications—both generic and brand-name—this provider has most frequently prescribed.
  • Specialization Insights: The types of drugs prescribed can give insight into the provider’s areas of focus or specialization, whether it’s managing chronic conditions, addressing acute illnesses, or providing preventive care.
  • Cost Awareness: Learn about the total drug costs associated with these prescriptions, which may help you anticipate your own costs and coverage needs.
  • Patient-Centered Decision Making: Understanding a provider’s prescribing practices helps you align their expertise with your health goals, ensuring the care you receive is consistent with your expectations.
Generic Name
Molnupiravir
Specialty
Nurse Practitioner
Times Prescribed
11
Number of 30-Day Refills Prescribed
11
What is this prescription used for?
Molnupiravir is a product that the FDA is allowing to be given for emergency use to treat COVID-19. It is used by adults 18 years of age and older who have recently tested positive for coronavirus, have had mild to moderate symptoms for no more than 5 days and are not hospitalized. To receive this product you must also be at high risk for COVID-19 complications due to older age, obesity, or ongoing medical conditions (such as lung or heart disease or diabetes, among others). Talk to your doctor about the risks and benefits of treatment with molnupiravir. Molnupiravir works by preventing the growth of the virus that causes COVID-19. More information about molnupiravir is available from the FDA Fact Sheet for Patients, Parents, and Caregivers for Emergency Use. There is limited information about how safe and effective molnupiravir is for treating COVID-19. Study results show that molnupiravir may help people who have recently tested positive for coronavirus stay out of the hospital. This product is not for use by people who are hospitalized due to COVID-19. The information in this document reflects emerging data, which is evolving and subject to reassessment. Users should be aware of these considerations in their review of molnupiravir, and it is always the responsibility of treating practitioners to exercise independent judgement in making care decisions.

This dataset provides information about prescriptions written for Medicare beneficiaries in the year 2022. It does not include prescriptions for patients with private insurance, Medicaid, or other coverage types. However, this information remains valuable for all patients, as it may reflect the provider's overall prescribing preferences and approach to pharmaceutical care. This can help you make better-informed decisions when considering or continuing care with this provider.